Research / GTEC / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-26-032928 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.58% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.21% · OPTIONAL · VALID
Revenue growth 60th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
8.04% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
26.88% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
31.36% · CORE · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
8.29% · CORE · VALID
R&D intensity 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.32% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.12% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Dec 31, 2021 6/7 normalized Level 3 Mar 31, 2022 6/7 normalized Level 3 Jun 30, 2022 5/6 normalized Level 3 Sep 30, 2022 5/6 normalized Level 3 Dec 31, 2022 6/6 normalized Level 3 Mar 31, 2023 6/6 normalized Level 3 Jun 30, 2023 6/6 normalized Level 3 Sep 30, 2023 6/6 normalized Level 3 Dec 31, 2023 6/6 normalized Level 3 Dec 31, 2022 6/6 normalized Amended as filed Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Jun 30, 2025 6/7 normalized Level 3 Sep 30, 2025 6/8 normalized Level 3 Dec 31, 2025 6/8 normalized Level 3 Mar 31, 2026 6/7 normalized Level 3 Jun 30, 2026 6/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.48%
Current 0.58%
Delta 0.10% Cash Generation Decreased
Previous 35.29%
Current 17.21%
Delta -18.08% Growth Decreased
Previous 24.25%
Current 8.04%
Delta -16.21% Inventory Pressure Decreased
Previous 101.96%
Current 26.88%
Delta -75.08% Margin Decreased
Previous 32.36%
Current 31.36%
Delta -1.00% Profitability Decreased
Previous 21.65%
Current 8.29%
Delta -13.35% R And D Intensity Increased
Previous 2.40%
Current 4.32%
Delta 1.93% Sbc Intensity Increased
Previous 0.00%
Current 6.12%
Delta 6.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.